Genenta Science S.p.A. Investing Cash Flow
Genenta Science S.p.A. (GNTA) reported Investing Cash Flow of -EUR 14.54 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-04-01
| Period end | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|
| 2025-12-31 | -14.54M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | -4.44M EUR 6-K · filed 2025-10-10 | |
| 2024-12-31 | 6.88M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 4.30M EUR 6-K · filed 2025-10-10 | |
| 2023-12-31 | -14.89M EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | -10.00M EUR 6-K · filed 2024-10-29 | |
| 2022-12-31 | -27.07K EUR 20-F · filed 2025-03-28 | |
| 2022-06-30 | -2.81K EUR 6-K · filed 2023-10-20 | |
| 2021-12-31 | -9.01K EUR 20-F · filed 2024-03-29 | |
| 2021-06-30 | -3.73K EUR 6-K · filed 2022-10-25 | |
| 2020-12-31 | -20.87K EUR 20-F · filed 2023-04-21 |